| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.99B | 19.11B | 17.93B | 34.54B | 22.27B | 12.77B |
| Gross Profit | 3.11B | 3.25B | 4.96B | 18.09B | 9.82B | 1.79B |
| EBITDA | 4.71B | 5.01B | 5.20B | 19.29B | 10.83B | 2.58B |
| Net Income | 2.36B | 2.39B | 2.94B | 17.03B | 9.07B | 926.80M |
Balance Sheet | ||||||
| Total Assets | 29.22B | 33.62B | 29.01B | 38.69B | 26.71B | 15.18B |
| Cash, Cash Equivalents and Short-Term Investments | 5.80B | 7.57B | 7.65B | 18.08B | 7.75B | 667.90M |
| Total Debt | 6.26B | 6.61B | 5.03B | 5.44B | 5.50B | 5.14B |
| Total Liabilities | 11.50B | 12.89B | 10.25B | 10.78B | 10.55B | 8.46B |
| Stockholders Equity | 17.66B | 20.65B | 18.69B | 27.89B | 16.15B | 6.71B |
Cash Flow | ||||||
| Free Cash Flow | 2.45B | 2.20B | 3.26B | 18.06B | 9.16B | 2.36B |
| Operating Cash Flow | 4.77B | 4.36B | 4.97B | 19.50B | 10.41B | 2.90B |
| Investing Cash Flow | -2.18B | -1.98B | -1.65B | -4.07B | -1.23B | -477.60M |
| Financing Cash Flow | -2.82B | -3.08B | -12.18B | -8.23B | -2.48B | -2.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | €1.09B | 14.09 | 7.17% | 1.89% | -5.27% | -13.70% | |
72 Outperform | €707.20M | 11.26 | 17.81% | 5.20% | 21.42% | -10.98% | |
71 Outperform | €20.70B | 8.77 | 13.10% | 7.13% | 19.74% | 208.29% | |
64 Neutral | €10.62B | 116.70 | 15.96% | 0.59% | 14.89% | 619.09% | |
57 Neutral | €2.07B | 58.87 | 5.02% | 0.47% | 16.39% | 87.55% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |